Global Pulmonary Drug Delivery Systems Market Insights and Forecast to 2028

TABLE OF CONTENTS

1 Study Coverage

• 1.1 Pulmonary Drug Delivery Systems Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Pulmonary Drug Delivery Systems Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
  • 1.2.2 Nebulizers
  • 1.2.3 Dry Powder Inhaler (DPI)
  • 1.2.4 Metered Dose Inhaler (MDI)
• 1.3 Market by Application
  • 1.3.1 Global Pulmonary Drug Delivery Systems Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
  • 1.3.2 COPD
  • 1.3.3 Asthma
  • 1.3.4 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Executive Summary

• 2.1 Global Pulmonary Drug Delivery Systems Sales Estimates and Forecasts 2017-2028
• 2.2 Global Pulmonary Drug Delivery Systems Revenue Estimates and Forecasts 2017-2028
• 2.3 Global Pulmonary Drug Delivery Systems Revenue by Region: 2017 VS 2021 VS 2028
• 2.4 Global Pulmonary Drug Delivery Systems Sales by Region
  • 2.4.1 Global Pulmonary Drug Delivery Systems Sales by Region (2017-2022)
  • 2.4.2 Global Sales Pulmonary Drug Delivery Systems by Region (2023-2028)
• 2.5 Global Pulmonary Drug Delivery Systems Revenue by Region
  • 2.5.1 Global Pulmonary Drug Delivery Systems Revenue by Region (2017-2022)
  • 2.5.2 Global Pulmonary Drug Delivery Systems Revenue by Region (2023-2028)
• 2.6 North America
• 2.7 Europe
• 2.8 Asia-Pacific
• 2.9 Latin America
• 2.10 Middle East & Africa

3 Competition by Manufacturers

• 3.1 Global Pulmonary Drug Delivery Systems Sales by Manufacturers
  • 3.1.1 Global Top Pulmonary Drug Delivery Systems Manufacturers by Sales (2017-2022)
  • 3.1.2 Global Pulmonary Drug Delivery Systems Sales Market Share by Manufacturers (2017-2022)
  • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Pulmonary Drug Delivery Systems in 2021
• 3.2 Global Pulmonary Drug Delivery Systems Revenue by Manufacturers
  • 3.2.1 Global Pulmonary Drug Delivery Systems Revenue by Manufacturers (2017-2022)
  • 3.2.2 Global Pulmonary Drug Delivery Systems Revenue Market Share by Manufacturers (2017-2022)
  • 3.2.3 Global Top 10 and Top 5 Companies by Pulmonary Drug Delivery Systems Revenue in 2021
• 3.3 Global Pulmonary Drug Delivery Systems Sales Price by Manufacturers (2017-2022)
• 3.4 Analysis of Competitive Landscape
  • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Pulmonary Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.4.3 Global Pulmonary Drug Delivery Systems Manufacturers Geographical Distribution
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Global Pulmonary Drug Delivery Systems Sales by Type
  • 4.1.1 Global Pulmonary Drug Delivery Systems Historical Sales by Type (2017-2022)
  • 4.1.2 Global Pulmonary Drug Delivery Systems Forecasted Sales by Type (2023-2028)
  • 4.1.3 Global Pulmonary Drug Delivery Systems Sales Market Share by Type (2017-2028)
• 4.2 Global Pulmonary Drug Delivery Systems Revenue by Type
  • 4.2.1 Global Pulmonary Drug Delivery Systems Historical Revenue by Type (2017-2022)
  • 4.2.2 Global Pulmonary Drug Delivery Systems Forecasted Revenue by Type (2023-2028)
  • 4.2.3 Global Pulmonary Drug Delivery Systems Revenue Market Share by Type (2017-2028)
• 4.3 Global Pulmonary Drug Delivery Systems Price by Type
  • 4.3.1 Global Pulmonary Drug Delivery Systems Price by Type (2017-2022)
  • 4.3.2 Global Pulmonary Drug Delivery Systems Price Forecast by Type (2023-2028)

5 Market Size by Application

• 5.1 Global Pulmonary Drug Delivery Systems Sales by Application
  • 5.1.1 Global Pulmonary Drug Delivery Systems Historical Sales by Application (2017-2022)
  • 5.1.2 Global Pulmonary Drug Delivery Systems Forecasted Sales by Application (2023-2028)
  • 5.1.3 Global Pulmonary Drug Delivery Systems Sales Market Share by Application (2017-2028)
• 5.2 Global Pulmonary Drug Delivery Systems Revenue by Application
  • 5.2.1 Global Pulmonary Drug Delivery Systems Historical Revenue by Application (2017-2022)
  • 5.2.2 Global Pulmonary Drug Delivery Systems Forecasted Revenue by Application (2023-2028)
  • 5.2.3 Global Pulmonary Drug Delivery Systems Revenue Market Share by Application (2017-2028)
• 5.3 Global Pulmonary Drug Delivery Systems Price by Application
  • 5.3.1 Global Pulmonary Drug Delivery Systems Price by Application (2017-2022)
  • 5.3.2 Global Pulmonary Drug Delivery Systems Price Forecast by Application (2023-2028)

6 North America

• 6.1 North America Pulmonary Drug Delivery Systems Market Size by Type
  • 6.1.1 North America Pulmonary Drug Delivery Systems Sales by Type (2017-2028)
  • 6.1.2 North America Pulmonary Drug Delivery Systems Revenue by Type (2017-2028)
• 6.2 North America Pulmonary Drug Delivery Systems Market Size by Application
  • 6.2.1 North America Pulmonary Drug Delivery Systems Sales by Application (2017-2028)
  • 6.2.2 North America Pulmonary Drug Delivery Systems Revenue by Application (2017-2028)
• 6.3 North America Pulmonary Drug Delivery Systems Market Size by Country
  • 6.3.1 North America Pulmonary Drug Delivery Systems Sales by Country (2017-2028)
  • 6.3.2 North America Pulmonary Drug Delivery Systems Revenue by Country (2017-2028)
  • 6.3.3 U.S.
  • 6.3.4 Canada

7 Europe

• 7.1 Europe Pulmonary Drug Delivery Systems Market Size by Type
  • 7.1.1 Europe Pulmonary Drug Delivery Systems Sales by Type (2017-2028)
  • 7.1.2 Europe Pulmonary Drug Delivery Systems Revenue by Type (2017-2028)
• 7.2 Europe Pulmonary Drug Delivery Systems Market Size by Application
  • 7.2.1 Europe Pulmonary Drug Delivery Systems Sales by Application (2017-2028)
  • 7.2.2 Europe Pulmonary Drug Delivery Systems Revenue by Application (2017-2028)
• 7.3 Europe Pulmonary Drug Delivery Systems Market Size by Country
  • 7.3.1 Europe Pulmonary Drug Delivery Systems Sales by Country (2017-2028)
  • 7.3.2 Europe Pulmonary Drug Delivery Systems Revenue by Country (2017-2028)
  • 7.3.3 Germany
  • 7.3.4 France
  • 7.3.5 U.K.
  • 7.3.6 Italy
  • 7.3.7 Russia

8 Asia Pacific

• 8.1 Asia Pacific Pulmonary Drug Delivery Systems Market Size by Type
  • 8.1.1 Asia Pacific Pulmonary Drug Delivery Systems Sales by Type (2017-2028)
  • 8.1.2 Asia Pacific Pulmonary Drug Delivery Systems Revenue by Type (2017-2028)
• 8.2 Asia Pacific Pulmonary Drug Delivery Systems Market Size by Application
  • 8.2.1 Asia Pacific Pulmonary Drug Delivery Systems Sales by Application (2017-2028)
  • 8.2.2 Asia Pacific Pulmonary Drug Delivery Systems Revenue by Application (2017-2028)
• 8.3 Asia Pacific Pulmonary Drug Delivery Systems Market Size by Region
  • 8.3.1 Asia Pacific Pulmonary Drug Delivery Systems Sales by Region (2017-2028)
  • 8.3.2 Asia Pacific Pulmonary Drug Delivery Systems Revenue by Region (2017-2028)
  • 8.3.3 China
  • 8.3.4 Japan
  • 8.3.5 South Korea
  • 8.3.6 India
  • 8.3.7 Australia
  • 8.3.8 China Taiwan
  • 8.3.9 Indonesia
  • 8.3.10 Thailand
  • 8.3.11 Malaysia

9 Latin America

• 9.1 Latin America Pulmonary Drug Delivery Systems Market Size by Type
  • 9.1.1 Latin America Pulmonary Drug Delivery Systems Sales by Type (2017-2028)
  • 9.1.2 Latin America Pulmonary Drug Delivery Systems Revenue by Type (2017-2028)
• 9.2 Latin America Pulmonary Drug Delivery Systems Market Size by Application
  • 9.2.1 Latin America Pulmonary Drug Delivery Systems Sales by Application (2017-2028)
  • 9.2.2 Latin America Pulmonary Drug Delivery Systems Revenue by Application (2017-2028)
• 9.3 Latin America Pulmonary Drug Delivery Systems Market Size by Country
  • 9.3.1 Latin America Pulmonary Drug Delivery Systems Sales by Country (2017-2028)
  • 9.3.2 Latin America Pulmonary Drug Delivery Systems Revenue by Country (2017-2028)
  • 9.3.3 Mexico
  • 9.3.4 Brazil
  • 9.3.5 Argentina

10 Middle East and Africa

• 10.1 Middle East and Africa Pulmonary Drug Delivery Systems Market Size by Type
  • 10.1.1 Middle East and Africa Pulmonary Drug Delivery Systems Sales by Type (2017-2028)
  • 10.1.2 Middle East and Africa Pulmonary Drug Delivery Systems Revenue by Type (2017-2028)
• 10.2 Middle East and Africa Pulmonary Drug Delivery Systems Market Size by Application
  • 10.2.1 Middle East and Africa Pulmonary Drug Delivery Systems Sales by Application (2017-2028)
  • 10.2.2 Middle East and Africa Pulmonary Drug Delivery Systems Revenue by Application (2017-2028)
• 10.3 Middle East and Africa Pulmonary Drug Delivery Systems Market Size by Country
  • 10.3.1 Middle East and Africa Pulmonary Drug Delivery Systems Sales by Country (2017-2028)
  • 10.3.2 Middle East and Africa Pulmonary Drug Delivery Systems Revenue by Country (2017-2028)
  • 10.3.3 Turkey
  • 10.3.4 Saudi Arabia

11 Company Profiles

• 11.1 3M
  • 11.1.1 3M Corporation Information
  • 11.1.2 3M Overview
  • 11.1.3 3M Pulmonary Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.1.4 3M Pulmonary Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.1.5 3M Recent Developments
• 11.2 GSK
  • 11.2.1 GSK Corporation Information
  • 11.2.2 GSK Overview
  • 11.2.3 GSK Pulmonary Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.2.4 GSK Pulmonary Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.2.5 GSK Recent Developments
• 11.3 AstraZeneca
  • 11.3.1 AstraZeneca Corporation Information
  • 11.3.2 AstraZeneca Overview
  • 11.3.3 AstraZeneca Pulmonary Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.3.4 AstraZeneca Pulmonary Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.3.5 AstraZeneca Recent Developments
• 11.4 Cipla
  • 11.4.1 Cipla Corporation Information
  • 11.4.2 Cipla Overview
  • 11.4.3 Cipla Pulmonary Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.4.4 Cipla Pulmonary Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.4.5 Cipla Recent Developments
• 11.5 Chiesi
  • 11.5.1 Chiesi Corporation Information
  • 11.5.2 Chiesi Overview
  • 11.5.3 Chiesi Pulmonary Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.5.4 Chiesi Pulmonary Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.5.5 Chiesi Recent Developments
• 11.6 Boehringer Ingelheim
  • 11.6.1 Boehringer Ingelheim Corporation Information
  • 11.6.2 Boehringer Ingelheim Overview
  • 11.6.3 Boehringer Ingelheim Pulmonary Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.6.4 Boehringer Ingelheim Pulmonary Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.6.5 Boehringer Ingelheim Recent Developments
• 11.7 Aptar
  • 11.7.1 Aptar Corporation Information
  • 11.7.2 Aptar Overview
  • 11.7.3 Aptar Pulmonary Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.7.4 Aptar Pulmonary Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.7.5 Aptar Recent Developments
• 11.8 Novartis
  • 11.8.1 Novartis Corporation Information
  • 11.8.2 Novartis Overview
  • 11.8.3 Novartis Pulmonary Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.8.4 Novartis Pulmonary Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.8.5 Novartis Recent Developments
• 11.9 Philips Respironics
  • 11.9.1 Philips Respironics Corporation Information
  • 11.9.2 Philips Respironics Overview
  • 11.9.3 Philips Respironics Pulmonary Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.9.4 Philips Respironics Pulmonary Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.9.5 Philips Respironics Recent Developments
• 11.10 Omron Healthcare
  • 11.10.1 Omron Healthcare Corporation Information
  • 11.10.2 Omron Healthcare Overview
  • 11.10.3 Omron Healthcare Pulmonary Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.10.4 Omron Healthcare Pulmonary Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.10.5 Omron Healthcare Recent Developments
• 11.11 PARI
  • 11.11.1 PARI Corporation Information
  • 11.11.2 PARI Overview
  • 11.11.3 PARI Pulmonary Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.11.4 PARI Pulmonary Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.11.5 PARI Recent Developments
• 11.12 Skyepharma
  • 11.12.1 Skyepharma Corporation Information
  • 11.12.2 Skyepharma Overview
  • 11.12.3 Skyepharma Pulmonary Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.12.4 Skyepharma Pulmonary Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.12.5 Skyepharma Recent Developments
• 11.13 CareFusion
  • 11.13.1 CareFusion Corporation Information
  • 11.13.2 CareFusion Overview
  • 11.13.3 CareFusion Pulmonary Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.13.4 CareFusion Pulmonary Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.13.5 CareFusion Recent Developments
• 11.14 Shanghai Huarui
  • 11.14.1 Shanghai Huarui Corporation Information
  • 11.14.2 Shanghai Huarui Overview
  • 11.14.3 Shanghai Huarui Pulmonary Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.14.4 Shanghai Huarui Pulmonary Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.14.5 Shanghai Huarui Recent Developments
• 11.15 Taian Character
  • 11.15.1 Taian Character Corporation Information
  • 11.15.2 Taian Character Overview
  • 11.15.3 Taian Character Pulmonary Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.15.4 Taian Character Pulmonary Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.15.5 Taian Character Recent Developments
• 11.16 Chia Tai Tianqing
  • 11.16.1 Chia Tai Tianqing Corporation Information
  • 11.16.2 Chia Tai Tianqing Overview
  • 11.16.3 Chia Tai Tianqing Pulmonary Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.16.4 Chia Tai Tianqing Pulmonary Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.16.5 Chia Tai Tianqing Recent Developments

12 Industry Chain and Sales Channels Analysis

• 12.1 Pulmonary Drug Delivery Systems Industry Chain Analysis
• 12.2 Pulmonary Drug Delivery Systems Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Pulmonary Drug Delivery Systems Production Mode & Process
• 12.4 Pulmonary Drug Delivery Systems Sales and Marketing
  • 12.4.1 Pulmonary Drug Delivery Systems Sales Channels
  • 12.4.2 Pulmonary Drug Delivery Systems Distributors
• 12.5 Pulmonary Drug Delivery Systems Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

• 13.1 Pulmonary Drug Delivery Systems Industry Trends
• 13.2 Pulmonary Drug Delivery Systems Market Drivers
• 13.3 Pulmonary Drug Delivery Systems Market Challenges
• 13.4 Pulmonary Drug Delivery Systems Market Restraints

14 Key Findings in The Global Pulmonary Drug Delivery Systems Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Author Details
• 15.3 Disclaimer

• Table 1. Global Pulmonary Drug Delivery Systems Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
• Table 2. Major Manufacturers of Nebulizers
• Table 3. Major Manufacturers of Dry Powder Inhaler (DPI)
• Table 4. Major Manufacturers of Metered Dose Inhaler (MDI)
• Table 5. Global Pulmonary Drug Delivery Systems Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
• Table 6. Global Pulmonary Drug Delivery Systems Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
• Table 7. Global Pulmonary Drug Delivery Systems Sales by Region (2017-2022) & (M Units)
• Table 8. Global Pulmonary Drug Delivery Systems Sales Market Share by Region (2017-2022)
• Table 9. Global Pulmonary Drug Delivery Systems Sales by Region (2023-2028) & (M Units)
• Table 10. Global Pulmonary Drug Delivery Systems Sales Market Share by Region (2023-2028)
• Table 11. Global Pulmonary Drug Delivery Systems Revenue by Region (2017-2022) & (US$ Million)
• Table 12. Global Pulmonary Drug Delivery Systems Revenue Market Share by Region (2017-2022)
• Table 13. Global Pulmonary Drug Delivery Systems Revenue by Region (2023-2028) & (US$ Million)
• Table 14. Global Pulmonary Drug Delivery Systems Revenue Market Share by Region (2023-2028)
• Table 15. Global Pulmonary Drug Delivery Systems Sales by Manufacturers (2017-2022) & (M Units)
• Table 16. Global Pulmonary Drug Delivery Systems Sales Share by Manufacturers (2017-2022)
• Table 17. Global Pulmonary Drug Delivery Systems Revenue by Manufacturers (2017-2022) & (US$ Million)
• Table 18. Global Pulmonary Drug Delivery Systems Revenue Share by Manufacturers (2017-2022)
• Table 19. Pulmonary Drug Delivery Systems Price by Manufacturers (2017-2022) &(US$/Unit)
• Table 20. Global Pulmonary Drug Delivery Systems Manufacturers Market Concentration Ratio (CR5 and HHI)
• Table 21. Global Pulmonary Drug Delivery Systems by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pulmonary Drug Delivery Systems as of 2021)
• Table 22. Pulmonary Drug Delivery Systems Manufacturing Base Distribution and Headquarters
• Table 23. Manufacturers Pulmonary Drug Delivery Systems Product Offered
• Table 24. Date of Manufacturers Enter into Pulmonary Drug Delivery Systems Market
• Table 25. Mergers & Acquisitions, Expansion Plans
• Table 26. Global Pulmonary Drug Delivery Systems Sales by Type (2017-2022) & (M Units)
• Table 27. Global Pulmonary Drug Delivery Systems Sales by Type (2023-2028) & (M Units)
• Table 28. Global Pulmonary Drug Delivery Systems Sales Share by Type (2017-2022)
• Table 29. Global Pulmonary Drug Delivery Systems Sales Share by Type (2023-2028)
• Table 30. Global Pulmonary Drug Delivery Systems Revenue by Type (2017-2022) & (US$ Million)
• Table 31. Global Pulmonary Drug Delivery Systems Revenue by Type (2023-2028) & (US$ Million)
• Table 32. Global Pulmonary Drug Delivery Systems Revenue Share by Type (2017-2022)
• Table 33. Global Pulmonary Drug Delivery Systems Revenue Share by Type (2023-2028)
• Table 34. Pulmonary Drug Delivery Systems Price by Type (2017-2022) & (US$/Unit)
• Table 35. Global Pulmonary Drug Delivery Systems Price Forecast by Type (2023-2028) & (US$/Unit)
• Table 36. Global Pulmonary Drug Delivery Systems Sales by Application (2017-2022) & (M Units)
• Table 37. Global Pulmonary Drug Delivery Systems Sales by Application (2023-2028) & (M Units)
• Table 38. Global Pulmonary Drug Delivery Systems Sales Share by Application (2017-2022)
• Table 39. Global Pulmonary Drug Delivery Systems Sales Share by Application (2023-2028)
• Table 40. Global Pulmonary Drug Delivery Systems Revenue by Application (2017-2022) & (US$ Million)
• Table 41. Global Pulmonary Drug Delivery Systems Revenue by Application (2023-2028) & (US$ Million)
• Table 42. Global Pulmonary Drug Delivery Systems Revenue Share by Application (2017-2022)
• Table 43. Global Pulmonary Drug Delivery Systems Revenue Share by Application (2023-2028)
• Table 44. Pulmonary Drug Delivery Systems Price by Application (2017-2022) & (US$/Unit)
• Table 45. Global Pulmonary Drug Delivery Systems Price Forecast by Application (2023-2028) & (US$/Unit)
• Table 46. North America Pulmonary Drug Delivery Systems Sales by Type (2017-2022) & (M Units)
• Table 47. North America Pulmonary Drug Delivery Systems Sales by Type (2023-2028) & (M Units)
• Table 48. North America Pulmonary Drug Delivery Systems Revenue by Type (2017-2022) & (US$ Million)
• Table 49. North America Pulmonary Drug Delivery Systems Revenue by Type (2023-2028) & (US$ Million)
• Table 50. North America Pulmonary Drug Delivery Systems Sales by Application (2017-2022) & (M Units)
• Table 51. North America Pulmonary Drug Delivery Systems Sales by Application (2023-2028) & (M Units)
• Table 52. North America Pulmonary Drug Delivery Systems Revenue by Application (2017-2022) & (US$ Million)
• Table 53. North America Pulmonary Drug Delivery Systems Revenue by Application (2023-2028) & (US$ Million)
• Table 54. North America Pulmonary Drug Delivery Systems Sales by Country (2017-2022) & (M Units)
• Table 55. North America Pulmonary Drug Delivery Systems Sales by Country (2023-2028) & (M Units)
• Table 56. North America Pulmonary Drug Delivery Systems Revenue by Country (2017-2022) & (US$ Million)
• Table 57. North America Pulmonary Drug Delivery Systems Revenue by Country (2023-2028) & (US$ Million)
• Table 58. Europe Pulmonary Drug Delivery Systems Sales by Type (2017-2022) & (M Units)
• Table 59. Europe Pulmonary Drug Delivery Systems Sales by Type (2023-2028) & (M Units)
• Table 60. Europe Pulmonary Drug Delivery Systems Revenue by Type (2017-2022) & (US$ Million)
• Table 61. Europe Pulmonary Drug Delivery Systems Revenue by Type (2023-2028) & (US$ Million)
• Table 62. Europe Pulmonary Drug Delivery Systems Sales by Application (2017-2022) & (M Units)
• Table 63. Europe Pulmonary Drug Delivery Systems Sales by Application (2023-2028) & (M Units)
• Table 64. Europe Pulmonary Drug Delivery Systems Revenue by Application (2017-2022) & (US$ Million)
• Table 65. Europe Pulmonary Drug Delivery Systems Revenue by Application (2023-2028) & (US$ Million)
• Table 66. Europe Pulmonary Drug Delivery Systems Sales by Country (2017-2022) & (M Units)
• Table 67. Europe Pulmonary Drug Delivery Systems Sales by Country (2023-2028) & (M Units)
• Table 68. Europe Pulmonary Drug Delivery Systems Revenue by Country (2017-2022) & (US$ Million)
• Table 69. Europe Pulmonary Drug Delivery Systems Revenue by Country (2023-2028) & (US$ Million)
• Table 70. Asia Pacific Pulmonary Drug Delivery Systems Sales by Type (2017-2022) & (M Units)
• Table 71. Asia Pacific Pulmonary Drug Delivery Systems Sales by Type (2023-2028) & (M Units)
• Table 72. Asia Pacific Pulmonary Drug Delivery Systems Revenue by Type (2017-2022) & (US$ Million)
• Table 73. Asia Pacific Pulmonary Drug Delivery Systems Revenue by Type (2023-2028) & (US$ Million)
• Table 74. Asia Pacific Pulmonary Drug Delivery Systems Sales by Application (2017-2022) & (M Units)
• Table 75. Asia Pacific Pulmonary Drug Delivery Systems Sales by Application (2023-2028) & (M Units)
• Table 76. Asia Pacific Pulmonary Drug Delivery Systems Revenue by Application (2017-2022) & (US$ Million)
• Table 77. Asia Pacific Pulmonary Drug Delivery Systems Revenue by Application (2023-2028) & (US$ Million)
• Table 78. Asia Pacific Pulmonary Drug Delivery Systems Sales by Region (2017-2022) & (M Units)
• Table 79. Asia Pacific Pulmonary Drug Delivery Systems Sales by Region (2023-2028) & (M Units)
• Table 80. Asia Pacific Pulmonary Drug Delivery Systems Revenue by Region (2017-2022) & (US$ Million)
• Table 81. Asia Pacific Pulmonary Drug Delivery Systems Revenue by Region (2023-2028) & (US$ Million)
• Table 82. Latin America Pulmonary Drug Delivery Systems Sales by Type (2017-2022) & (M Units)
• Table 83. Latin America Pulmonary Drug Delivery Systems Sales by Type (2023-2028) & (M Units)
• Table 84. Latin America Pulmonary Drug Delivery Systems Revenue by Type (2017-2022) & (US$ Million)
• Table 85. Latin America Pulmonary Drug Delivery Systems Revenue by Type (2023-2028) & (US$ Million)
• Table 86. Latin America Pulmonary Drug Delivery Systems Sales by Application (2017-2022) & (M Units)
• Table 87. Latin America Pulmonary Drug Delivery Systems Sales by Application (2023-2028) & (M Units)
• Table 88. Latin America Pulmonary Drug Delivery Systems Revenue by Application (2017-2022) & (US$ Million)
• Table 89. Latin America Pulmonary Drug Delivery Systems Revenue by Application (2023-2028) & (US$ Million)
• Table 90. Latin America Pulmonary Drug Delivery Systems Sales by Country (2017-2022) & (M Units)
• Table 91. Latin America Pulmonary Drug Delivery Systems Sales by Country (2023-2028) & (M Units)
• Table 92. Latin America Pulmonary Drug Delivery Systems Revenue by Country (2017-2022) & (US$ Million)
• Table 93. Latin America Pulmonary Drug Delivery Systems Revenue by Country (2023-2028) & (US$ Million)
• Table 94. Middle East and Africa Pulmonary Drug Delivery Systems Sales by Type (2017-2022) & (M Units)
• Table 95. Middle East and Africa Pulmonary Drug Delivery Systems Sales by Type (2023-2028) & (M Units)
• Table 96. Middle East and Africa Pulmonary Drug Delivery Systems Revenue by Type (2017-2022) & (US$ Million)
• Table 97. Middle East and Africa Pulmonary Drug Delivery Systems Revenue by Type (2023-2028) & (US$ Million)
• Table 98. Middle East and Africa Pulmonary Drug Delivery Systems Sales by Application (2017-2022) & (M Units)
• Table 99. Middle East and Africa Pulmonary Drug Delivery Systems Sales by Application (2023-2028) & (M Units)
• Table 100. Middle East and Africa Pulmonary Drug Delivery Systems Revenue by Application (2017-2022) & (US$ Million)
• Table 101. Middle East and Africa Pulmonary Drug Delivery Systems Revenue by Application (2023-2028) & (US$ Million)
• Table 102. Middle East and Africa Pulmonary Drug Delivery Systems Sales by Country (2017-2022) & (M Units)
• Table 103. Middle East and Africa Pulmonary Drug Delivery Systems Sales by Country (2023-2028) & (M Units)
• Table 104. Middle East and Africa Pulmonary Drug Delivery Systems Revenue by Country (2017-2022) & (US$ Million)
• Table 105. Middle East and Africa Pulmonary Drug Delivery Systems Revenue by Country (2023-2028) & (US$ Million)
• Table 106. 3M Corporation Information
• Table 107. 3M Description and Major Businesses
• Table 108. 3M Pulmonary Drug Delivery Systems Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
• Table 109. 3M Pulmonary Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
• Table 110. 3M Recent Developments
• Table 111. GSK Corporation Information
• Table 112. GSK Description and Major Businesses
• Table 113. GSK Pulmonary Drug Delivery Systems Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
• Table 114. GSK Pulmonary Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
• Table 115. GSK Recent Developments
• Table 116. AstraZeneca Corporation Information
• Table 117. AstraZeneca Description and Major Businesses
• Table 118. AstraZeneca Pulmonary Drug Delivery Systems Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
• Table 119. AstraZeneca Pulmonary Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
• Table 120. AstraZeneca Recent Developments
• Table 121. Cipla Corporation Information
• Table 122. Cipla Description and Major Businesses
• Table 123. Cipla Pulmonary Drug Delivery Systems Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
• Table 124. Cipla Pulmonary Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
• Table 125. Cipla Recent Developments
• Table 126. Chiesi Corporation Information
• Table 127. Chiesi Description and Major Businesses
• Table 128. Chiesi Pulmonary Drug Delivery Systems Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
• Table 129. Chiesi Pulmonary Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
• Table 130. Chiesi Recent Developments
• Table 131. Boehringer Ingelheim Corporation Information
• Table 132. Boehringer Ingelheim Description and Major Businesses
• Table 133. Boehringer Ingelheim Pulmonary Drug Delivery Systems Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
• Table 134. Boehringer Ingelheim Pulmonary Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
• Table 135. Boehringer Ingelheim Recent Developments
• Table 136. Aptar Corporation Information
• Table 137. Aptar Description and Major Businesses
• Table 138. Aptar Pulmonary Drug Delivery Systems Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
• Table 139. Aptar Pulmonary Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
• Table 140. Aptar Recent Developments
• Table 141. Novartis Corporation Information
• Table 142. Novartis Description and Major Businesses
• Table 143. Novartis Pulmonary Drug Delivery Systems Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
• Table 144. Novartis Pulmonary Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
• Table 145. Novartis Recent Developments
• Table 146. Philips Respironics Corporation Information
• Table 147. Philips Respironics Description and Major Businesses
• Table 148. Philips Respironics Pulmonary Drug Delivery Systems Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
• Table 149. Philips Respironics Pulmonary Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
• Table 150. Philips Respironics Recent Developments
• Table 151. Omron Healthcare Corporation Information
• Table 152. Omron Healthcare Description and Major Businesses
• Table 153. Omron Healthcare Pulmonary Drug Delivery Systems Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
• Table 154. Omron Healthcare Pulmonary Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
• Table 155. Omron Healthcare Recent Developments
• Table 156. PARI Corporation Information
• Table 157. PARI Description and Major Businesses
• Table 158. PARI Pulmonary Drug Delivery Systems Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
• Table 159. PARI Pulmonary Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
• Table 160. PARI Recent Developments
• Table 161. Skyepharma Corporation Information
• Table 162. Skyepharma Description and Major Businesses
• Table 163. Skyepharma Pulmonary Drug Delivery Systems Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
• Table 164. Skyepharma Pulmonary Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
• Table 165. Skyepharma Recent Developments
• Table 166. CareFusion Corporation Information
• Table 167. CareFusion Description and Major Businesses
• Table 168. CareFusion Pulmonary Drug Delivery Systems Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
• Table 169. CareFusion Pulmonary Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
• Table 170. CareFusion Recent Developments
• Table 171. Shanghai Huarui Corporation Information
• Table 172. Shanghai Huarui Description and Major Businesses
• Table 173. Shanghai Huarui Pulmonary Drug Delivery Systems Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
• Table 174. Shanghai Huarui Pulmonary Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
• Table 175. Shanghai Huarui Recent Developments
• Table 176. Taian Character Corporation Information
• Table 177. Taian Character Description and Major Businesses
• Table 178. Taian Character Pulmonary Drug Delivery Systems Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
• Table 179. Taian Character Pulmonary Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
• Table 180. Taian Character Recent Developments
• Table 181. Chia Tai Tianqing Corporation Information
• Table 182. Chia Tai Tianqing Description and Major Businesses
• Table 183. Chia Tai Tianqing Pulmonary Drug Delivery Systems Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
• Table 184. Chia Tai Tianqing Pulmonary Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
• Table 185. Chia Tai Tianqing Recent Developments
• Table 186. Key Raw Materials Lists
• Table 187. Raw Materials Key Suppliers Lists
• Table 188. Pulmonary Drug Delivery Systems Distributors List
• Table 189. Pulmonary Drug Delivery Systems Customers List
• Table 190. Pulmonary Drug Delivery Systems Market Trends
• Table 191. Pulmonary Drug Delivery Systems Market Drivers
• Table 192. Pulmonary Drug Delivery Systems Market Challenges
• Table 193. Pulmonary Drug Delivery Systems Market Restraints
• Table 194. Research Programs/Design for This Report
• Table 195. Key Data Information from Secondary Sources
• Table 196. Key Data Information from Primary Sources

List of Figures

• Figure 1. Pulmonary Drug Delivery Systems Product Picture
• Figure 3. Global Pulmonary Drug Delivery Systems Market Share by Type in 2021 & 2028
• Figure 3. Nebulizers Product Picture
• Figure 4. Dry Powder Inhaler (DPI) Product Picture
• Figure 5. Metered Dose Inhaler (MDI) Product Picture
• Figure 6. Global Pulmonary Drug Delivery Systems Market Share by Application in 2021 & 2028
• Figure 7. COPD
• Figure 8. Asthma
• Figure 9. Others
• Figure 10. Pulmonary Drug Delivery Systems Report Years Considered
• Figure 11. Global Pulmonary Drug Delivery Systems Sales 2017-2028 (M Units)
• Figure 12. Global Pulmonary Drug Delivery Systems Revenue, (US$ Million), 2017 VS 2021 VS 2028
• Figure 13. Global Pulmonary Drug Delivery Systems Revenue 2017-2028 (US$ Million)
• Figure 14. Global Pulmonary Drug Delivery Systems Revenue Market Share by Region in Percentage: 2021 Versus 2028
• Figure 15. Global Pulmonary Drug Delivery Systems Sales Market Share by Region (2017-2022)
• Figure 16. Global Pulmonary Drug Delivery Systems Sales Market Share by Region (2023-2028)
• Figure 17. North America Pulmonary Drug Delivery Systems Sales YoY (2017-2028) & (M Units)
• Figure 18. North America Pulmonary Drug Delivery Systems Revenue YoY (2017-2028) & (US$ Million)
• Figure 19. Europe Pulmonary Drug Delivery Systems Sales YoY (2017-2028) & (M Units)
• Figure 20. Europe Pulmonary Drug Delivery Systems Revenue YoY (2017-2028) & (US$ Million)
• Figure 21. Asia-Pacific Pulmonary Drug Delivery Systems Sales YoY (2017-2028) & (M Units)
• Figure 22. Asia-Pacific Pulmonary Drug Delivery Systems Revenue YoY (2017-2028) & (US$ Million)
• Figure 23. Latin America Pulmonary Drug Delivery Systems Sales YoY (2017-2028) & (M Units)
• Figure 24. Latin America Pulmonary Drug Delivery Systems Revenue YoY (2017-2028) & (US$ Million)
• Figure 25. Middle East & Africa Pulmonary Drug Delivery Systems Sales YoY (2017-2028) & (M Units)
• Figure 26. Middle East & Africa Pulmonary Drug Delivery Systems Revenue YoY (2017-2028) & (US$ Million)
• Figure 27. The Pulmonary Drug Delivery Systems Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
• Figure 28. The Top 5 and 10 Largest Manufacturers of Pulmonary Drug Delivery Systems in the World: Market Share by Pulmonary Drug Delivery Systems Revenue in 2021
• Figure 29. Global Pulmonary Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
• Figure 30. Global Pulmonary Drug Delivery Systems Sales Market Share by Type (2017-2028)
• Figure 31. Global Pulmonary Drug Delivery Systems Revenue Market Share by Type (2017-2028)
• Figure 32. Global Pulmonary Drug Delivery Systems Sales Market Share by Application (2017-2028)
• Figure 33. Global Pulmonary Drug Delivery Systems Revenue Market Share by Application (2017-2028)
• Figure 34. North America Pulmonary Drug Delivery Systems Sales Market Share by Type (2017-2028)
• Figure 35. North America Pulmonary Drug Delivery Systems Revenue Market Share by Type (2017-2028)
• Figure 36. North America Pulmonary Drug Delivery Systems Sales Market Share by Application (2017-2028)
• Figure 37. North America Pulmonary Drug Delivery Systems Revenue Market Share by Application (2017-2028)
• Figure 38. North America Pulmonary Drug Delivery Systems Sales Share by Country (2017-2028)
• Figure 39. North America Pulmonary Drug Delivery Systems Revenue Share by Country (2017-2028)
• Figure 40. U.S. Pulmonary Drug Delivery Systems Revenue (2017-2028) & (US$ Million)
• Figure 41. Canada Pulmonary Drug Delivery Systems Revenue (2017-2028) & (US$ Million)
• Figure 42. Europe Pulmonary Drug Delivery Systems Sales Market Share by Type (2017-2028)
• Figure 43. Europe Pulmonary Drug Delivery Systems Revenue Market Share by Type (2017-2028)
• Figure 44. Europe Pulmonary Drug Delivery Systems Sales Market Share by Application (2017-2028)
• Figure 45. Europe Pulmonary Drug Delivery Systems Revenue Market Share by Application (2017-2028)
• Figure 46. Europe Pulmonary Drug Delivery Systems Sales Share by Country (2017-2028)
• Figure 47. Europe Pulmonary Drug Delivery Systems Revenue Share by Country (2017-2028)
• Figure 48. Germany Pulmonary Drug Delivery Systems Revenue (2017-2028) & (US$ Million)
• Figure 49. France Pulmonary Drug Delivery Systems Revenue (2017-2028) & (US$ Million)
• Figure 50. U.K. Pulmonary Drug Delivery Systems Revenue (2017-2028) & (US$ Million)
• Figure 51. Italy Pulmonary Drug Delivery Systems Revenue (2017-2028) & (US$ Million)
• Figure 52. Russia Pulmonary Drug Delivery Systems Revenue (2017-2028) & (US$ Million)
• Figure 53. Asia Pacific Pulmonary Drug Delivery Systems Sales Market Share by Type (2017-2028)
• Figure 54. Asia Pacific Pulmonary Drug Delivery Systems Revenue Market Share by Type (2017-2028)
• Figure 55. Asia Pacific Pulmonary Drug Delivery Systems Sales Market Share by Application (2017-2028)
• Figure 56. Asia Pacific Pulmonary Drug Delivery Systems Revenue Market Share by Application (2017-2028)
• Figure 57. Asia Pacific Pulmonary Drug Delivery Systems Sales Share by Region (2017-2028)
• Figure 58. Asia Pacific Pulmonary Drug Delivery Systems Revenue Share by Region (2017-2028)
• Figure 59. China Pulmonary Drug Delivery Systems Revenue (2017-2028) & (US$ Million)
• Figure 60. Japan Pulmonary Drug Delivery Systems Revenue (2017-2028) & (US$ Million)
• Figure 61. South Korea Pulmonary Drug Delivery Systems Revenue (2017-2028) & (US$ Million)
• Figure 62. India Pulmonary Drug Delivery Systems Revenue (2017-2028) & (US$ Million)
• Figure 63. Australia Pulmonary Drug Delivery Systems Revenue (2017-2028) & (US$ Million)
• Figure 64. China Taiwan Pulmonary Drug Delivery Systems Revenue (2017-2028) & (US$ Million)
• Figure 65. Indonesia Pulmonary Drug Delivery Systems Revenue (2017-2028) & (US$ Million)
• Figure 66. Thailand Pulmonary Drug Delivery Systems Revenue (2017-2028) & (US$ Million)
• Figure 67. Malaysia Pulmonary Drug Delivery Systems Revenue (2017-2028) & (US$ Million)
• Figure 68. Latin America Pulmonary Drug Delivery Systems Sales Market Share by Type (2017-2028)
• Figure 69. Latin America Pulmonary Drug Delivery Systems Revenue Market Share by Type (2017-2028)
• Figure 70. Latin America Pulmonary Drug Delivery Systems Sales Market Share by Application (2017-2028)
• Figure 71. Latin America Pulmonary Drug Delivery Systems Revenue Market Share by Application (2017-2028)
• Figure 72. Latin America Pulmonary Drug Delivery Systems Sales Share by Country (2017-2028)
• Figure 73. Latin America Pulmonary Drug Delivery Systems Revenue Share by Country (2017-2028)
• Figure 74. Mexico Pulmonary Drug Delivery Systems Revenue (2017-2028) & (US$ Million)
• Figure 75. Brazil Pulmonary Drug Delivery Systems Revenue (2017-2028) & (US$ Million)
• Figure 76. Argentina Pulmonary Drug Delivery Systems Revenue (2017-2028) & (US$ Million)
• Figure 77. Middle East and Africa Pulmonary Drug Delivery Systems Sales Market Share by Type (2017-2028)
• Figure 78. Middle East and Africa Pulmonary Drug Delivery Systems Revenue Market Share by Type (2017-2028)
• Figure 79. Middle East and Africa Pulmonary Drug Delivery Systems Sales Market Share by Application (2017-2028)
• Figure 80. Middle East and Africa Pulmonary Drug Delivery Systems Revenue Market Share by Application (2017-2028)
• Figure 81. Middle East and Africa Pulmonary Drug Delivery Systems Sales Share by Country (2017-2028)
• Figure 82. Middle East and Africa Pulmonary Drug Delivery Systems Revenue Share by Country (2017-2028)
• Figure 83. Turkey Pulmonary Drug Delivery Systems Revenue (2017-2028) & (US$ Million)
• Figure 84. Saudi Arabia Pulmonary Drug Delivery Systems Revenue (2017-2028) & (US$ Million)
• Figure 85. UAE Pulmonary Drug Delivery Systems Revenue (2017-2028) & (US$ Million)
• Figure 86. Pulmonary Drug Delivery Systems Value Chain
• Figure 87. Pulmonary Drug Delivery Systems Production Process
• Figure 88. Channels of Distribution
• Figure 89. Distributors Profiles
• Figure 90. Bottom-up and Top-down Approaches for This Report
• Figure 91. Data Triangulation
• Figure 92. Key Executives Interviewed